BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Arthramid - ECPv6.15.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Arthramid
X-ORIGINAL-URL:https://arthramid.com/eur/
X-WR-CALDESC:Events for Arthramid
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251022T080000
DTEND;TZID=America/Los_Angeles:20251025T170000
DTSTAMP:20260423T203021
CREATED:20250915T023755Z
LAST-MODIFIED:20251007T084817Z
UID:10016-1761120000-1761411600@arthramid.com
SUMMARY:Contura Vet at ACVS 2025
DESCRIPTION:This year’s ACVS Surgery Summit\, taking place October 23–25\, is one of the veterinary industry’s most influential forums\, uniting surgeons\, specialists\, and researchers dedicated to advancing clinical excellence. The program highlights the latest innovations in orthopedics\, sports medicine\, and regenerative therapies\, shaping the future of patient care across both small and large animals. \nThis year’s ACVS program features new Arthramid® data and translational insights that will directly shape the future of joint health across species. \n\nSee the latest data first: including new 0–84 day canine elbow OA results and equine osteoarthritis model findings.\nHear directly from leading experts like Dr. Matthew Brunke and Dr. Lisa Fortier as they present cutting-edge research.\nDiscover translational insights across the One Health continuum\, linking human and veterinary joint care.\nStay ahead in orthopedics and regenerative medicine with evidence that’s reshaping treatment approaches for dogs\, horses\, and beyond.\n\n  \nPoster Presentations\n2.5% Polyacrylamide Gel in Canine Elbow OA (0–84 Day Data)  \nSpeaker: Matthew Brunke DVM\, DAVSMR\, CCAT\nWhen: Thursday\, October 23\, poster \nOwner-Reported Outcomes Indicate Intra-Articular 2.5% Polyacrylamide Hydrogel (2.5% iPAAG) Injection is Well-Tolerated and Reduces Osteoarthritis Signs in Dogs \nSpeaker: Matthew Brunke DVM\, DAVSMR\, CCAT\nWhen: Thursday\, October 23\, poster \n2.5% Hydrogel in an Equine Osteoarthritis Model \nSpeaker: Katie Seabaugh DVM\, DACVS\, DACVSMR\nWhen: Thursday\, October 23\, poster \nArthramid and the One Health Continuum: Translational Insights in Synovitis and Osteoarthritis\nSpeakers: Matthew Brunke DVM\, DAVSMR\, CCAT\, Lisa Fortier DVM\, PhD\, DACVS and Courtney Campbell DVM\, DACVS\nWhen: Saturday\, October 25 at 12:15 EST podium \nLUNCH SPONSORED BY CONTURA VET
URL:https://arthramid.com/eur/event/contura-at-acvs-2025/
LOCATION:Seattle\, Washington\, United States
CATEGORIES:CANINE,EQUINE,IN-PERSON
ATTACH;FMTTYPE=image/png:https://arthramid.com/wp-content/uploads/ACVS-FINAL-LogoFrameTag-e1757902848872.png
END:VEVENT
END:VCALENDAR